Serina Therapeutics, Inc.
General ticker "SER" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $48.9M (TTM average)
Serina Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -25.5%.
Estimated limits based on current volatility of 10.3%: low 1.69$, high 2.07$
Factors to consider:
- Total employees count: 12 as of 2018
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.71$, 5.04$]
- 2026-12-31 to 2027-12-31 estimated range: [1.61$, 4.64$]
Short-term SER quotes
Long-term SER plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3.15MM | $0.06MM | $0.13MM |
| Operating Expenses | $6.28MM | $17.10MM | $24.15MM |
| Operating Income | $-3.13MM | $-17.05MM | $-24.02MM |
| Non-Operating Income | $8.40MM | $5.84MM | $4.83MM |
| Interest Expense | $0.56MM | $0.53MM | $0.21MM |
| R&D Expense | $2.39MM | $7.48MM | $13.15MM |
| Income(Loss) | $5.27MM | $-11.21MM | $-19.20MM |
| Taxes | $0.00MM | $0.00MM | $0.02MM |
| Profit(Loss)* | $5.27MM | $-11.14MM | $-19.44MM |
| Stockholders Equity | $-32.29MM | $0.64MM | $-0.04MM |
| Assets | $8.97MM | $6.72MM | $6.95MM |
| Operating Cash Flow | $-2.48MM | $-17.14MM | $-17.95MM |
| Capital expenditure | $0.50MM | $0.02MM | $0.06MM |
| Investing Cash Flow | $-0.50MM | $-0.02MM | $-0.06MM |
| Financing Cash Flow | $10.07MM | $13.21MM | $17.41MM |
| Earnings Per Share** | $0.63 | $-1.51 | $-1.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.